Clinical trials
Withdrawn Non-alcoholic Fatty Liver Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical College of Wisconsin | 4 |
| BioMarin Pharmaceutical | 1 |
| Columbia University | 1 |
| Erchonia Corporation | 1 |
| Fibronostics USA, Inc | 1 |
| Massachusetts General Hospital | 1 |
| Methodist Health System | 1 |
| Northwell Health | 1 |
| University of Missouri-Columbia | 1 |
| University of Southern California | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 15 |
| Fatty Liver | 5 |
| Obesity | 5 |
| Diabetes Mellitus | 3 |
| Fibrosis | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Hyperinsulinism | 1 |
| Hyperoxaluria | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.